Schwab Charles Investment Management Inc. boosted its stake in Medical Properties Trust, Inc. (NYSE:MPW) by 7.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,023,941 shares of the real estate investment trust’s stock after acquiring an additional 148,707 shares during the quarter. Schwab Charles Investment Management Inc. owned 0.56% of Medical Properties Trust worth $27,890,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Ffcm LLC acquired a new position in Medical Properties Trust in the 3rd quarter valued at about $116,000. Investors Asset Management of Georgia Inc. GA ADV bought a new stake in shares of Medical Properties Trust during the 4th quarter worth approximately $138,000. Mcmillion Capital Management Inc. bought a new stake in shares of Medical Properties Trust during the 3rd quarter worth approximately $137,000. Janus Henderson Group PLC bought a new stake in shares of Medical Properties Trust during the 2nd quarter worth approximately $136,000. Finally, Cetera Investment Advisers bought a new stake in shares of Medical Properties Trust during the 2nd quarter worth approximately $141,000. 80.07% of the stock is currently owned by institutional investors and hedge funds.
In other news, Chairman Edward K. Aldag, Jr. sold 489,971 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $12.39, for a total value of $6,070,740.69. Following the completion of the sale, the chairman now directly owns 2,192,629 shares in the company, valued at approximately $27,166,673.31. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.00% of the company’s stock.
Medical Properties Trust, Inc. (MPW) traded up $0.03 on Thursday, hitting $12.98. 1,619,558 shares of the stock traded hands, compared to its average volume of 2,560,000. The stock has a market capitalization of $4,730.00, a P/E ratio of 15.83, a price-to-earnings-growth ratio of 2.55 and a beta of 0.82. Medical Properties Trust, Inc. has a 52-week low of $11.82 and a 52-week high of $14.22. The company has a debt-to-equity ratio of 1.28, a current ratio of 2.06 and a quick ratio of 2.06.
Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Thursday, February 8th. The real estate investment trust reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. Medical Properties Trust had a net margin of 41.12% and a return on equity of 7.85%. The company had revenue of $205.00 million during the quarter, compared to analysts’ expectations of $204.52 million. During the same quarter in the previous year, the company earned $0.31 earnings per share. Medical Properties Trust’s revenue for the quarter was up 33.7% on a year-over-year basis. research analysts expect that Medical Properties Trust, Inc. will post 1.43 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 12th. Shareholders of record on Thursday, March 15th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, March 14th. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a yield of 7.70%. Medical Properties Trust’s payout ratio is presently 117.07%.
MPW has been the subject of several research reports. Robert W. Baird downgraded shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and dropped their price objective for the company from $15.00 to $13.00 in a research note on Friday, January 5th. JPMorgan Chase & Co. upgraded shares of Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price target for the company in a research report on Friday, December 15th. Deutsche Bank cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $14.00 to $13.50 in a research report on Wednesday, January 10th. Zacks Investment Research cut shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. Finally, ValuEngine upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Thursday, November 9th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $14.33.
COPYRIGHT VIOLATION WARNING: This piece was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://ledgergazette.com/2018/03/09/schwab-charles-investment-management-inc-has-27-89-million-stake-in-medical-properties-trust-inc-mpw.html.
About Medical Properties Trust
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.